MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
公司代碼MDXG
公司名稱MiMedx Group Inc
上市日期Aug 20, 2007
CEOCapper (Joseph H)
員工數量837
證券類型Ordinary Share
年結日Aug 20
公司地址1775 W Oak Commons Court, Ne
城市MARIETTA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編30062
電話17706519100
網址https://mimedx.com/
公司代碼MDXG
上市日期Aug 20, 2007
CEOCapper (Joseph H)